Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Peripheral Artery Disease · Muscle-Invasive Bladder Carcinoma

Blackmores Institute

Blackmores Limited

Blackmores Institute patent portfolio — 38 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
20 Jubilee Ave, Warriewood, New South Wales 2102, AU HQ
2012 Founded
27 Employees
TGA registrant Type
Company details
Status
Public
HQ
20 Jubilee Ave, Warriewood, New South Wales 2102, AU
Founded
2012
Employees
27
Programs
17
Drugs
24
Patents
38
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Blackmores Institute patents

38 pharmaceutical patents indexed for Blackmores Institute. 1 expire within 24 months.

Blackmores Institute has 38 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

38 patents

Patent portfolio

  1. US 12343394

    CD38 modulating antibody agents

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12325699

    Antibacterial compounds

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12304964

    CD38 modulating antibody

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12187754

    LpxC inhibitors and uses thereof

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12161717

    CD38 modulating antibody agents

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12162949

    CD38 antibody

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11897873

    Kappa opioid receptor antagonists and products and methods related thereto

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11780930

    CD38 modulating antibody

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11691011

    Pain-relieving apparatus

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11542338

    CD38 modulating antibody

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11236173

    CD38 antibody

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11186577

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11124504

    Kappa opioid receptor antagonists and products and methods related thereto

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11034672

    Tyrosine kinase inhibitor compositions, methods of making and methods of use

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10897915

    Method for making coffee products containing cannabis ingredients

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10829485

    ATF6 inhibitors and uses thereof

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10702629

    Conditioning harvested fat for re-injection

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10676469

    Kappa opioid receptor antagonists and products and methods related thereto

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10538530

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10405560

    Method for making coffee products containing cannabis ingredients

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10135517

    Relay link HARQ operation

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9900622

    Multiple sign bit hiding within a transform unit

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9737560

    Process for preparation of a humic substance based gel for targeted external application

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9730972

    Skin tightening lotion

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9687441

    Compositions for use with a fascia tissue treatment device to reduce cellulite

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9439216

    Relay link HARQ operation

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9008184

    Multiple sign bit hiding within a transform unit

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7537421

    Dead spindle PTO with compliant grounding mechanism

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7105558

    Gastrin and cholecystokinin receptor lignads (iv)

    Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7034048

    Gastrin and cholecystokinin receptor ligands (III)

    Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6956053

    Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands

    Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6878734

    Gastrin and cholecystokinin receptor ligands(II)

    Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6878736

    Histamine H3 receptor ligands

    Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6479531

    Gastrin and cholecystokinin receptor ligands

    Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6407132

    Substituted imidazole derivatives and their use as histamine H3 receptor ligands

    Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6159994

    Histamine H.sub.3 receptor ligands

    Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6080871

    Sulfonamides and sulfamides as H.sub.3 receptor antagonists

    Expires Mon Jun 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6057311

    Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors

    Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Blackmores Institute have?

38 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Blackmores Institute patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.